SI0801948T1 - Ophthalmic composition having prolonged residence time in the eye - Google Patents

Ophthalmic composition having prolonged residence time in the eye

Info

Publication number
SI0801948T1
SI0801948T1 SI9730178T SI9730178T SI0801948T1 SI 0801948 T1 SI0801948 T1 SI 0801948T1 SI 9730178 T SI9730178 T SI 9730178T SI 9730178 T SI9730178 T SI 9730178T SI 0801948 T1 SI0801948 T1 SI 0801948T1
Authority
SI
Slovenia
Prior art keywords
eye
preserving agent
residence time
ophthalmic composition
ammonium salt
Prior art date
Application number
SI9730178T
Other languages
English (en)
Inventor
Guenther Dr Bellmann
Gudrun Dr Claus-Herz
Original Assignee
Gerhard Mann Chemisch Pharmaze
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gerhard Mann Chemisch Pharmaze filed Critical Gerhard Mann Chemisch Pharmaze
Publication of SI0801948T1 publication Critical patent/SI0801948T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SI9730178T 1996-04-15 1997-03-06 Ophthalmic composition having prolonged residence time in the eye SI0801948T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19614823A DE19614823A1 (de) 1996-04-15 1996-04-15 Ophthalmische Zusammensetzung mit verlängerter Verweilzeit am Auge
EP97103736A EP0801948B1 (de) 1996-04-15 1997-03-06 Ophtalmische Zusammensetzung mit verlängerter Verweilzeit am Auge

Publications (1)

Publication Number Publication Date
SI0801948T1 true SI0801948T1 (en) 2001-10-31

Family

ID=7791310

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9730178T SI0801948T1 (en) 1996-04-15 1997-03-06 Ophthalmic composition having prolonged residence time in the eye

Country Status (16)

Country Link
US (2) US6599944B1 (xx)
EP (1) EP0801948B1 (xx)
JP (1) JP4582822B2 (xx)
CN (1) CN1215988A (xx)
AT (1) ATE201820T1 (xx)
AU (1) AU714093B2 (xx)
BR (1) BR9708669A (xx)
CA (1) CA2251982C (xx)
DE (2) DE19614823A1 (xx)
DK (1) DK0801948T3 (xx)
ES (1) ES2159783T3 (xx)
GR (1) GR3036498T3 (xx)
PL (1) PL187339B1 (xx)
PT (1) PT801948E (xx)
SI (1) SI0801948T1 (xx)
WO (1) WO1997038674A1 (xx)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19614823A1 (de) 1996-04-15 1997-10-16 Mann Gerhard Chem Pharm Fab Ophthalmische Zusammensetzung mit verlängerter Verweilzeit am Auge
DE19744113A1 (de) * 1997-10-06 1999-04-15 Mann Gerhard Chem Pharm Fab Dexamethason-Gel
IN185228B (xx) * 1999-02-03 2000-12-09 Bakulesh Mafatlal Dr Khamar
DE19918324A1 (de) * 1999-04-22 2000-10-26 Mann Gerhard Chem Pharm Fab Pharmazeutische Zusammensetzung wirksam gegen durch Bakterien, Viren, Pilze, Hefen und Protozoen verursachte Krankheitszustände
DE19938668B4 (de) * 1999-08-14 2006-01-26 Bausch & Lomb Inc. Tränenersatzmittel
DE10132876A1 (de) * 2001-07-06 2003-01-30 Medproject Pharma Entwicklungs Zweiphasige, tropfbare Hydrogele zur Anwendung am Auge
US8545487B2 (en) * 2007-12-05 2013-10-01 Avedro Inc. Eye therapy system
WO2010039854A1 (en) * 2008-09-30 2010-04-08 Neal Marshall Eye therapy system
WO2011050164A1 (en) 2009-10-21 2011-04-28 Avedro, Inc. Eye therapy
US20110237999A1 (en) * 2010-03-19 2011-09-29 Avedro Inc. Systems and methods for applying and monitoring eye therapy
WO2012162529A1 (en) 2011-05-24 2012-11-29 Avedro, Inc. Systems and methods for reshaping an eye feature
US9020580B2 (en) 2011-06-02 2015-04-28 Avedro, Inc. Systems and methods for monitoring time based photo active agent delivery or photo active marker presence
CN102416011A (zh) * 2011-10-10 2012-04-18 艾硕特生物科技（昆明）有限公司 一种广谱、高效的抗菌洗液
US9827191B2 (en) 2012-05-03 2017-11-28 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
US10688041B2 (en) 2012-05-03 2020-06-23 Kala Pharmaceuticals, Inc. Compositions and methods utilizing poly(vinyl alcohol) and/or other polymers that aid particle transport in mucus
JP6360039B2 (ja) 2012-05-03 2018-07-18 カラ ファーマシューティカルズ インコーポレイテッド 複数の被覆された粒子を含む組成物、医薬組成物、医薬製剤、及び当該粒子の形成方法
US11596599B2 (en) 2012-05-03 2023-03-07 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
EP2872081B1 (en) 2012-07-16 2022-06-08 Avedro, Inc. Systems for corneal cross-linking with pulsed light
WO2014205145A1 (en) 2013-06-18 2014-12-24 Avedro, Inc. Systems and methods for determining biomechanical properties of the eye for applying treatment
US9498114B2 (en) 2013-06-18 2016-11-22 Avedro, Inc. Systems and methods for determining biomechanical properties of the eye for applying treatment
US9308165B2 (en) * 2013-08-22 2016-04-12 Therapeutic Vision, Inc. Composition for treating ocular effects of diabetes
WO2016069628A1 (en) 2014-10-27 2016-05-06 Avedro, Inc. Systems and methods for cross-linking treatments of an eye
WO2016077747A1 (en) 2014-11-13 2016-05-19 Avedro, Inc. Multipass virtually imaged phased array etalon
WO2016172695A1 (en) 2015-04-24 2016-10-27 Avedro, Inc. Systems and methods for photoactivating a photosensitizer applied to an eye
EP3297589A4 (en) 2015-05-22 2019-03-06 Avedro Inc. SYSTEMS AND METHOD FOR MONITORING THE NETWORKING ACTIVITY FOR CORNEAL TREATMENTS
JP6933377B2 (ja) 2015-07-21 2021-09-08 アヴェドロ・インコーポレーテッドＡｖｅｄｒｏ，Ｉｎｃ． 光増感剤を用いた眼の処置用システム及び方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1399834A (en) * 1971-05-12 1975-07-02 Fisons Ltd Pharmaceutical compositions
US4053628A (en) * 1971-05-12 1977-10-11 Fisons Limited Composition
AU499860B2 (en) * 1975-04-24 1979-05-03 Honda Giken Kogyo Kabushiki Kaisha Deflector plate to equalise fuel distribution in induction gas flow
JPS5313588A (en) * 1976-07-23 1978-02-07 Alcon Lab Inc Ophthalmic solution
GB2013084B (en) * 1978-01-25 1982-07-28 Alcon Lab Inc Ophthalmic drug dosage
US4271143A (en) * 1978-01-25 1981-06-02 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
DE3415663A1 (de) * 1984-04-27 1985-10-31 Sandoz-Patent-GmbH, 7850 Lörrach Eine neue ophthalmologische verabreichungsform
US4738851A (en) * 1985-09-27 1988-04-19 University Of Iowa Research Foundation, Inc. Controlled release ophthalmic gel formulation
US5032392A (en) * 1986-09-04 1991-07-16 Vision Pharmaceuticals Aqueous ophthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes
FR2665635A1 (fr) 1990-08-10 1992-02-14 Merck Sharp & Dohme Composition pharmaceutique fluide a base d'un complexe metallique et son procede de preparation.
FR2678832B1 (fr) 1991-07-10 1995-03-17 Europhta Sa Laboratoire Nouvelles compositions ophtalmiques a resorption amelioree et leurs procedes de preparation.
FR2679773A1 (fr) 1991-07-30 1993-02-05 Merck Sharp & Dohme Preparation ophtalmique contenant un agent osmotique acceptable antimicrobien.
AU5599594A (en) * 1992-11-16 1994-06-08 Ciba-Geigy Ag Polyvinyl alcohol/borate ophthalmic drug delivery system
WO1994015597A1 (en) * 1993-01-11 1994-07-21 Allergan, Inc. Ophthalmic compositions comprising benzyllauryldimethylammonium chloride
DE19614823A1 (de) 1996-04-15 1997-10-16 Mann Gerhard Chem Pharm Fab Ophthalmische Zusammensetzung mit verlängerter Verweilzeit am Auge

Also Published As

Publication number Publication date
WO1997038674A1 (de) 1997-10-23
ATE201820T1 (de) 2001-06-15
PL328656A1 (en) 1999-02-15
CA2251982C (en) 2008-01-29
DE59703711D1 (de) 2001-07-12
CN1215988A (zh) 1999-05-05
US6599944B1 (en) 2003-07-29
CA2251982A1 (en) 1997-10-23
EP0801948B1 (de) 2001-06-06
PT801948E (pt) 2001-10-31
PL187339B1 (pl) 2004-06-30
GR3036498T3 (en) 2001-11-30
EP0801948A1 (de) 1997-10-22
DE19614823A1 (de) 1997-10-16
AU714093B2 (en) 1999-12-16
DK0801948T3 (da) 2001-09-10
BR9708669A (pt) 1999-08-03
AU2024697A (en) 1997-11-07
US20040071778A1 (en) 2004-04-15
JP4582822B2 (ja) 2010-11-17
JP2000508646A (ja) 2000-07-11
ES2159783T3 (es) 2001-10-16

Similar Documents

Publication Publication Date Title
GR3036498T3 (en) Ophthalmic composition having prolonged residence time in the eye
DE69715049D1 (de) Tranilast enthaltendes externum und verfahren zu dessen herstellung
AU2824600A (en) Cosmetics
MX9705954A (es) Formulaciones y metodos para reducir irritacion de la piel.
ATE241334T1 (de) Mittel zur förderung des haarwachstums
NZ328898A (en) Sustained release formulation containing collagen and glycosaminoglycan additives
ATE163259T1 (de) Mittel zur regulierung vom hautfettigkeitsgrad
BR9407910A (pt) Composto composiçao farmacêutica uso do composto processo de tratamento de distúrbios no sistema nervoso central e processo de preparaçao do composto
MY135988A (en) Additive for improving the water resistance of cosmetic or dermatological formulations
NZ505742A (en) Compositions containing aminobiguanides with antimicrobial activity used to treat contact lenses
DE69010263D1 (de) Zahnreinigende Zusammensetzungen.
ATE363267T1 (de) Mittel zur verbesserung der hauttextur
AU2001259801A1 (en) 3-methoxybenzyl thiourea derivatives and improved lipid compositions containing same
AU1169999A (en) Aqueous ophthalmic formulations comprising chitosan
EP0372603A3 (en) Antibacterial oral composition
AU2360592A (en) Polyacrylic acid based ophthalmic compositions
WO2003070180A3 (en) Compositions and methods for delivery of skin cosmeceuticals
WO1996028151A3 (en) Use of a pyruvate dehydrogenase activator for the treatment of ischaemia in limbs
IT1283324B1 (it) Composizioni veterinarie a base di antibatterici per uso intramammario
CA2244679A1 (en) Tranilast-containing preparation for external application and method of producing the same
IT1271674B (it) Composizione per uso cosmetico includente oligoelementi
WO1996018406A3 (en) Ophthalmic formulations of substituted glycosides